BLISS GVS PHARMA
Back to Cashflow Statement
|
BLISS GVS PHARMA Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹-1.27 Cr | ₹1.62 Cr | ₹19 Cr | ₹-3.82 Cr | ₹-7.50 Cr |
What is the latest Net Cash Inflow / Outflow ratio of BLISS GVS PHARMA ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹-1.27 Cr |
Mar2023 | ₹1.62 Cr |
Mar2022 | ₹19 Cr |
Mar2021 | ₹-3.82 Cr |
Mar2020 | ₹-7.50 Cr |
How is Net Cash Inflow / Outflow of BLISS GVS PHARMA Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹-1.27 Cr | Negative | |
Mar2023 | ₹1.62 Cr | -91.35 | |
Mar2022 | ₹19 Cr | Positive | |
Mar2021 | ₹-3.82 Cr | Negative | |
Mar2020 | ₹-7.50 Cr | - |
Compare Net Cash Inflow / Outflow of peers of BLISS GVS PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BLISS GVS PHARMA | ₹1,660.1 Cr | -11.2% | -9.4% | 26.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,936.0 Cr | -5.8% | -3.2% | 35.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹152,157.0 Cr | -2.8% | -3.6% | 44.7% | Stock Analytics | |
CIPLA | ₹116,200.0 Cr | -3.9% | -0.5% | 13.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹111,325.0 Cr | -1.2% | 7.1% | 17.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,037.4 Cr | -2.7% | -0.1% | 40.9% | Stock Analytics |
BLISS GVS PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BLISS GVS PHARMA | -11.2% |
-9.4% |
26.4% |
SENSEX | -2.1% |
-6.4% |
7% |
You may also like the below Video Courses